A unique renal neoplasm characterized by eosinophilic cytoplasm and solid and cystic growth was recently reported in patients with tuberous sclerosis complex (TSC). We searched multiple institutional archives and consult files in an attempt to identify a sporadic counterpart. We identified 16 morphologically identical cases, all in women, without clinical features of TSC. The median age was 57 years (range, 31 to 75 y). Macroscopically, tumors were tan and had a solid and macrocystic (12) or only solid appearance (4). Average tumor size was 50 mm (median, 38.5 mm; range, 15 to 135 mm). Microscopically, the tumors showed solid areas admixed with variably sized macrocysts and microcysts that were lined by cells with a pronounced hobnail arrangement. The cells had voluminous eosinophilic cytoplasm with prominent granular cytoplasmic stippling and round to oval nuclei with prominent nucleoli. Scattered histiocytes and lymphocytes were invariably present. Thirteen of 16 patients were stage pT1; 2 were pT2, and 1 was pT3a. The cells demonstrated a distinct immunoprofile: nuclear PAX8 expression, predominant CK20-positive/CK7-negative phenotype, patchy AMACR staining, but no CD117 reactivity. Thirteen of 14 patients with follow-up were alive and without disease progression after 2 to 138 months (mean: 53 mo; median: 37.5 mo); 1 patient died of other causes. Although similar to a subset of renal cell carcinomas (RCCs) seen in TSC, we propose that sporadic "eosinophilic, solid, and cystic RCC," which occurs predominantly in female individuals and is characterized by distinct morphologic features, predominant CK20-positive/CK7-negative immunophenotype, and indolent behavior, represents a novel subtype of RCC.

*Calgary Laboratory Services and University of Calgary Calgary AB Canada †Department of Pathology Charles University Pilsen Czech Republic ‡Cruces University Hospital BioCruces Institute University of the Basque Country Barakaldo Bizkaia Spain §Nephropath Little Rock AR ‡‡Medical College Wisconsin Milwaukee WI §§El Camino Hospital Mountain View ∥∥Stanford University Hospital Stanford CA ¶¶New York University Medical Center New York NY ***Robert J Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic Cleveland OH ∥Carregi Hospital Florence Italy ¶Pitié Salpêtrière Hospital Hopital Cochin Paris France **Barts Cancer Institute Queen Mary University of London London United Kingdom ††University Hospital Dubrava Zagreb Croatia Royal North Shore Hospital University of Sydney Sydney NSW Australia

Citace poskytuje Crossref.org

Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists

TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background

New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer

Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach

"High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases